🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

3 recruiting trials

for Locally Advanced or Metastatic Solid Tumors With PIK3CA-mutated

REC-7735 in Participants With Solid Tumors NCT07819136Phase 1, Phase 23 sites📍 Grand Rapids📍 Irving📍 Fairfax Recursion Pharmaceuticals Inc. · Tests: REC-7735 GenSci145 as Monotherapy or in Combination Therapy, in Participants With PIK3CA-mutated, Locally Advanced or Metastatic Solid Tumors. NCT07407504Phase 11 site📍 Beijing Changchun GeneScience Pharmaceutical Co., Ltd. · Tests: GenSci145 tablets Study of RGT-490 in Patients With PIK3CA-Mutated Advanced Solid Tumors NCT07524322Phase 15 sites📍 Los Angeles📍 Houston📍 Houston Regor Pharmaceuticals Inc. · Tests: RGT-490
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy